Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2015 | Research article

Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study

Authors: Tung-Han Wu, Li-Yu Hu, Ti Lu, Pan-Ming Chen, Hon-Jhe Chen, Cheng-Che Shen, Chun-Hsien Wen

Published in: The Journal of Headache and Pain | Issue 1/2015

Abstract

Background

TN is one of the most common causes of facial pain. A higher prevalence of psychiatric co-morbidities, especially depressive disorder, has been proven in patients with TN; however, a clear temporal-causal relationship between TN and specific psychiatric disorders has not been well established. We performed a nationwide population-based retrospective cohort study to explore the relationship between TN and the subsequent development of psychiatric disorders, including schizophrenia, bipolar disorder, depressive disorder, anxiety disorder, and sleep disorder.

Methods

We identified subjects who were newly diagnosed with TN between January 1, 2000 and December 31, 2010 in the Taiwan National Health Insurance Research Database. A comparison cohort was constructed for patients without TN who were matched according to age and sex. All TN and control patients were observed until diagnosed with psychiatric disorders, death, withdrawal from the National Health Institute system, or until December 31, 2010.

Results

The TN cohort consisted of 3273 patients, and the comparison cohort consisted of 13,092 matched control patients without TN. The adjusted hazard ratio (aHR) of depressive disorder, anxiety disorder and sleep disorder in subjects with TN was higher than that of the controls during the follow-up [aHR: 2.85 (95 % confidence interval: 2.11–3.85), aHR: 2.98 (95 % confidence interval: 2.12–4.18) and aHR: 2.17 (95 % confidence interval: 1.48–3.19), respectively].

Conclusions

TN might increase the risk of subsequent newly diagnosed depressive disorder, anxiety disorder, and sleep disorder, but not schizophrenia or bipolar disorder. Additional prospective studies are required to confirm these findings.

Obermann M, Yoon MS, Ese D, Maschke M, Kaube H, Diener HC, Katsarava Z (2007) Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology 69(9):835–841. doi:10.1212/01.wnl.0000269670.30045.6b PubMedCrossRef

Obermann M, Holle D, Katsarava Z (2011) Trigeminal neuralgia and persistent idiopathic facial pain. Expert Rev Neurother 11(11):1619–1629. doi:10.1586/ern.11.156 PubMedCrossRef

The International Classification of Headache Disorders (2013) 3rd edition (beta version). Cephalalgia : Int J Headache 33(9):629–808. doi:10.1177/0333102413485658 CrossRef

Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT (1991) Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945–1984. Neuroepidemiology 10(5–6):276–281PubMedCrossRef

MacDonald BK, Cockerell OC, Sander JW, Shorvon SD (2000) The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain : J Neurol 123(Pt 4):665–676CrossRef

Katusic S, Beard CM, Bergstralh E, Kurland LT (1990) Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945–1984. Ann Neurol 27(1):89–95. doi:10.1002/ana.410270114 PubMedCrossRef

Cruccu G, Iannetti GD, Marx JJ, Thoemke F, Truini A, Fitzek S, Galeotti F, Urban PP, Romaniello A, Stoeter P, Manfredi M, Hopf HC (2005) Brainstem reflex circuits revisited. Brain : J Neurol 128(Pt 2):386–394. doi:10.1093/brain/awh366

Herweh C, Kress B, Rasche D, Tronnier V, Troger J, Sartor K, Stippich C (2007) Loss of anisotropy in trigeminal neuralgia revealed by diffusion tensor imaging. Neurology 68(10):776–778. doi:10.1212/01.wnl.0000256340.16766.1d PubMedCrossRef

Cruccu G, Biasiotta A, Di Rezze S, Fiorelli M, Galeotti F, Innocenti P, Mameli S, Millefiorini E, Truini A (2009) Trigeminal neuralgia and pain related to multiple sclerosis. Pain 143(3):186–191. doi:10.1016/j.pain.2008.12.026 PubMedCrossRef

10.

Jia DZ, Li G (2010) Bioresonance hypothesis: a new mechanism on the pathogenesis of trigeminal neuralgia. Med Hypotheses 74(3):505–507. doi:10.1016/j.mehy.2009.09.056 PubMedCrossRef

11.

Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D, Forte A, Girardi N, De Filippis S, Tatarelli R, Martelletti P (2010) Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat 6:81–91PubMedCentralPubMedCrossRef

12.

Puca F, Headaches ICGftSoPFiP (2000) Psychological and social stressors and psychiatric comorbidity in patients with migraine without aura from headache centers in Italy: a comparison with tension-type headache patients. J Headache Pain 1(1):17–25PubMedCentralCrossRef

13.

Smitherman TA, Baskin SM (2008) Headache secondary to psychiatric disorders. Curr Pain Headache Rep 12(4):305–310PubMedCrossRef

14.

Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM (2000) Headache and major depression: is the association specific to migraine? Neurology 54(2):308–313PubMedCrossRef

15.

Zakrzewska JM (2013) Multi-dimensionality of chronic pain of the oral cavity and face. J Headache Pain 14(1):37. doi:10.1186/1129-2377-14-37 PubMedCentralPubMedCrossRef

16.

Hals EKB, Stubhaug A (2011) Mental and somatic co-morbidities in chronic orofacial pain conditions: Pain patients in need of multiprofessional team approach. Scandinavian J Pain 2(4):153–154. doi:10.1016/j.sjpain.2011.08.003 CrossRef

17.

Devor M, Wood I, Sharav Y, Zakrzewska JM (2008) Trigeminal neuralgia during sleep. Pain practice : the official journal of World Institute of Pain 8(4):263–268. doi:10.1111/j.1533-2500.2008.00214.x CrossRef

18.

Sabalys G, Juodzbalys G, Wang HL (2013) Aetiology and pathogenesis of trigeminal neuralgia: a comprehensive review. J Oral Maxillofac Res 3(4), e2. doi:10.5037/jomr.2012.3402 PubMedCentralPubMed

19.

Sawaya RA (2000) Trigeminal neuralgia associated with sinusitis. ORL J Otorhinolaryngol Relat Spec 62(3):160–163.PubMedCrossRef

20.

Lin YW, Lin SK, Weng IH (2006) Fatal paranasal sinusitis presenting as trigeminal neuralgia. Headache 46(1):174–178. doi:10.1111/j.1526-4610.2006.00316_5.x PubMedCrossRef

21.

Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood–brain barrier. Nat Rev Neurosci 7(1):41–53. doi:10.1038/nrn1824 PubMedCrossRef

22.

Lampa J, Westman M, Kadetoff D, Agreus AN, Le Maitre E, Gillis-Haegerstrand C, Andersson M, Khademi M, Corr M, Christianson CA, Delaney A, Yaksh TL, Kosek E, Svensson CI (2012) Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice. Proc Natl Acad Sci U S A 109(31):12728–12733. doi:10.1073/pnas.1118748109 PubMedCentralPubMedCrossRef

23.

Leza JC, Bueno BG, Bioque M, Arango C, Parellada M, Do K, O’Donnell P, Bernardo M (2015) Inflammation in schizophrenia: A question of balance. Neurosci Biobehav Rev. doi:10.1016/j.neubiorev.2015.05.014

24.

Patel JP, Frey BN (2015) Disruption in the Blood–brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder? Neural Plast 2015:708306. doi:10.1155/2015/708306 PubMedCentralPubMed

25.

Rudich Z, Lerman SF, Gurevich B, Shahar G (2010) Pain specialists’ evaluation of patient’s prognosis during the first visit predicts subsequent depression and the affective dimension of pain. Pain Med (Malden, Mass) 11(3):446–452. doi:10.1111/j.1526-4637.2009.00795.x CrossRef

26.

Meskal I, Rutten GJ, Beute GN, Salden ME, Sitskoorn MM (2014) Cognitive deficits in patients with trigeminal neuralgia: opportunities to improve care and quality of life. Acta Neurochir 156(8):1565–1566. doi:10.1007/s00701-014-2100-2 PubMedCrossRef

27.

Hart RP, Martelli MF, Zasler ND (2000) Chronic pain and neuropsychological functioning. Neuropsychol Rev 10(3):131–149PubMedCrossRef

28.

Hart RP, Wade JB, Martelli MF (2003) Cognitive impairment in patients with chronic pain: the significance of stress. Curr Pain Headache Rep 7(2):116–126PubMedCrossRef

29.

Moriarty O, McGuire BE, Finn DP (2011) The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol 93(3):385–404. doi:10.1016/j.pneurobio.2011.01.002 PubMedCrossRef

30.

Cavanna AE, Ali F, Rickards HE, McCorry D (2010) Behavioral and cognitive effects of anti-epileptic drugs. Discov Med 9(45):138–44 (1944-7930 (Electronic))PubMed

31.

Mitolo M, Venneri A, Wilkinson ID, Sharrack B (2015) Cognitive rehabilitation in multiple sclerosis: A systematic review. J Neurol Sci 354(1–2):1–9. doi:10.1016/j.jns.2015.05.004 PubMedCrossRef

32.

Tolle T, Dukes E, Sadosky A (2006) Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Pain practice : the official journal of World Institute of Pain 6(3):153–160. doi:10.1111/j.1533-2500.2006.00079.x CrossRef

33.

Mitchell AJ, Kemp S, Benito-León J, Reuber M (2010) The influence of cognitive impairment on health-related quality of life in neurological disease. Acta Neuropsychiatr 22(1):2–13. doi:10.1111/j.1601-5215.2009.00439.x CrossRef

34.

He CH, Yu F, Jiang ZC, Wang JY, Luo F (2014) Fearful thinking predicts hypervigilance towards pain-related stimuli in patients with chronic pain. PsyCh J 3(3):189–200. doi:10.1002/pchj.57 PubMedCrossRef

35.

Lin FC, Tsai CP, Kuang-Wu Lee J, Wu MT, Tzu-Chi Lee C (2015) Angiotensin-converting enzyme inhibitors and amyotrophic lateral sclerosis risk: a total population-based case–control study. JAMA Neurol 72(1):40–48. doi:10.1001/jamaneurol.2014.3367 PubMedCrossRef

36.

Wang YP, Chen YT, Tsai CF, Li SY, Luo JC, Wang SJ, Tang CH, Liu CJ, Lin HC, Lee FY, Chang FY, Lu CL (2014) Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding. Am J Psychiatry 171(1):54–61. doi:10.1176/appi.ajp.2013.12111467 PubMedCrossRef

37.

Arap A, Siqueira SR, Silva CB, Teixeira MJ, Siqueira JT (2010) Trigeminal pain and quantitative sensory testing in painful peripheral diabetic neuropathy. Arch Oral Biol 55(7):486–493. doi:10.1016/j.archoralbio.2010.03.021 PubMedCrossRef

38.

Pan SL, Yen MF, Chiu YH, Chen LS, Chen HH (2011) Increased risk of trigeminal neuralgia after hypertension: a population-based study. Neurology 77(17):1605–1610. doi:10.1212/WNL.0b013e3182343354 PubMedCrossRef

39.

Teruel A, Ram S, Kumar SK, Hariri S, Clark GT (2009) Prevalence of hypertension in patients with trigeminal neuralgia. J Headache Pain 10(3):199–201. doi:10.1007/s10194-009-0107-5 PubMedCentralPubMedCrossRef

40.

El-Tallawy HN, Farghaly WM, Rageh TA, Shehata GA, Abdel Hakeem MN, Badry R, Kandil MR (2013) Prevalence of trigeminal neuralgia in Al-Quseir city (Red sea Governorate), Egypt. Clin Neurol Neurosurg 115(9):1792–1794. doi:10.1016/j.clineuro.2013.04.014 PubMedCrossRef

41.

Duransoy YK, Mete M, Akcay E, Selcuki M (2013) Differences in individual susceptibility affect the development of trigeminal neuralgia. Neural Regen Res 8(14):1337–1342. doi:10.3969/j.issn.1673-5374.2013.14.010 PubMedCentralPubMed

42.

Bendtsen L, Birk S, Kasch H, Aegidius K, Sorensen PS, Thomsen LL, Poulsen L, Rasmussen MJ, Kruuse C, Jensen R (2012) Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition. J Headache Pain 13(Suppl 1):S1–29. doi:10.1007/s10194-011-0402-9 PubMedCrossRef

43.

Di Stefano G, La Cesa S, Truini A, Cruccu G (2014) Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain 15:34. doi:10.1186/1129-2377-15-34 PubMedCentralPubMedCrossRef

44.

Rahman T, Campbell A, O'Connell CR, Nallapula K (2014) Carbamazepine in bipolar disorder with pain: reviewing treatment guidelines. The primary care companion for CNS disorders 16 (5). doi:10.4088/PCC.14r01672

45.

Smith JG, Elias LA, Yilmaz Z, Barker S, Shah K, Shah S, Renton T (2013) The psychosocial and affective burden of posttraumatic neuropathy following injuries to the trigeminal nerve. J Orofac Pain 27(4):293–303. doi:10.11607/jop.1056 PubMedCrossRef

46.

Macianskyte D, Januzis G, Kubilius R, Adomaitiene V, Sciupokas A (2011) Associations between chronic pain and depressive symptoms in patients with trigeminal neuralgia. Medicina (Kaunas, Lithuania) 47(7):386–392

47.

Blier P, Abbott FV (2001) Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry & Neurosci : JPN 26(1):37–43

48.

Berney A, Nishikawa M, Benkelfat C, Debonnel G, Gobbi G, Diksic M (2008) An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study. Neurochem Int 52(4–5):701–708. doi:10.1016/j.neuint.2007.08.021 PubMedCrossRef

49.

Strittmatter M, Grauer M, Isenberg E, Hamann G, Fischer C, Hoffmann KH, Blaes F, Schimrigk K (1997) Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. Headache 37(4):211–216PubMedCrossRef

50.

Gold PW (2015) The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry 20(1):32–47. doi:10.1038/mp.2014.163 PubMedCrossRef

51.

Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157(5):683–694PubMedCrossRef

52.

Devor M, Amir R, Rappaport ZH (2002) Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain 18(1):4–13PubMedCrossRef

53.

Devor M, Govrin-Lippmann R, Rappaport ZH (2002) Mechanism of trigeminal neuralgia: an ultrastructural analysis of trigeminal root specimens obtained during microvascular decompression surgery. J Neurosurg 96(3):532–543. doi:10.3171/jns.2002.96.3.0532 PubMedCrossRef

54.

Angulo MC, Kozlov AS, Charpak S, Audinat E (2004) Glutamate released from glial cells synchronizes neuronal activity in the hippocampus. J Neurosci : J Soc Neurosci 24(31):6920–6927. doi:10.1523/jneurosci.0473-04.2004 CrossRef

55.

Molina LA, Skelin I, Gruber AJ (2014) Acute NMDA receptor antagonism disrupts synchronization of action potential firing in rat prefrontal cortex. PLoS One 9(1), e85842. doi:10.1371/journal.pone.0085842 PubMedCentralPubMedCrossRef

56.

Iwata K, Imamura Y, Honda K, Shinoda M (2011) Physiological mechanisms of neuropathic pain: the orofacial region. Int Rev Neurobiol 97:227–250. doi:10.1016/b978-0-12-385198-7.00009-6 PubMedCrossRef

57.

Sessle BJ (2011) Peripheral and central mechanisms of orofacial inflammatory pain. Int Rev Neurobiol 97:179–206. doi:10.1016/b978-0-12-385198-7.00007-2 PubMedCrossRef

58.

Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH (1999) Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56(11):1043–1047PubMedCrossRef

59.

Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC (2007) Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64(2):193–200. doi:10.1001/archpsyc.64.2.193 PubMedCrossRef

60.

Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47(4):351–354PubMedCrossRef

61.

Rodriguez CI, Kegeles LS, Levinson A, Feng T, Marcus SM, Vermes D, Flood P, Simpson HB (2013) Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 38(12):2475–2483. doi:10.1038/npp.2013.150 CrossRef

62.

Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS (2014) Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 71(6):681–688. doi:10.1001/jamapsychiatry.2014.62 PubMedCrossRef

Title: Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study
Authors: Tung-Han Wu
Li-Yu Hu
Ti Lu
Pan-Ming Chen
Hon-Jhe Chen
Cheng-Che Shen
Chun-Hsien Wen
Publication date: 01-12-2015
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2015
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/s10194-015-0548-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Ictal epileptic headache revealing non convulsive status epilepticus in a case of eyelid myoclonia with absences

Impact of headache disorders in Italy and the public-health and policy implications: a population-based study within the Eurolight Project

Alexithymic characteristics in pediatric patients with primary headache: a comparison between migraine and tension-type headache

Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine

Migraine equivalents and related symptoms, psychological profile and headache features: which relationship?

Diagnostic criteria for temporomandibular disorders: self-instruction or formal training and calibration?